Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 4 institutions in 3 countries.
Leydi M MorenoGrupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, Cali 760042, Colombia.
Jairo QuirogaGrupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, Cali 760042, Colombia.ORCID 0000-0002-9451-3063
Rodrigo AboniaGrupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, Cali 760042, Colombia.ORCID 0000-0003-3256-0961
María Del P CrespoGrupo de Biotecnología e Infecciones Bacterianas, Departamento de Microbiología, Universidad del Valle, Cali 760042, Colombia.ORCID 0000-0003-2160-5167
Carlos AranagaGrupo de Investigación en Química y Biotecnología (QUIBIO), Facultad de Ciencias Básicas, Universidad Santiago de Cali, Cali 760035, Colombia.ORCID 0000-0003-1806-657X
Luis Martínez-MartínezUnidad de Microbiología Clínica, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Departamento de Química Agrícola, Edafología y Microbiología, Universidad de Córdoba, 14004 Córdoba, Spain.ORCID 0000-0002-6091-4045
Maximiliano SortinoÁrea de Farmacognosia, Facultad de Ciencias Bioquímicas y Farmacéuticas, Universidad Nacional de Rosario, Suipacha 531, Rosario 2000, Argentina.ORCID 0000-0002-4271-1690
Mauricio BarretoGrupo de Microbiología y Enfermedades Infecciosas, Departamento de Microbiología, Universidad del Valle, Cali 760042, Colombia.ORCID 0000-0001-5361-4901
María E BurbanoGrupo de Microbiología y Enfermedades Infecciosas, Departamento de Microbiología, Universidad del Valle, Cali 760042, Colombia.
Braulio InsuastyGrupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, Cali 760042, Colombia.ORCID 0000-0001-8371-3310
Universidad del Valle · COInstituto Maimónides de Investigación Biomédica de Córdoba · ESNational University of Rosario · ARUniversidad Santiago de Cali · CO
Funding
Colciencias FP-266-2017Universidad Santiago de Cali 934-621121-2847
6 · The paper itself
Abstract
This study presents the synthesis of four series of novel hybrid chalcones (
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Synthesis of Novel Triazine-Based Chalcones and 8,9-dihydro-7 · full record | OpenQuestion